- Home
- TAC vs TXG Comparison
TAC vs TXG Comparison
Compare TAC & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TAC | TXG |
|---|---|---|
| Founded | 1909 | 2012 |
| Country | Canada | United States |
| Employees | 1350 | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.6B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | TAC | TXG |
|---|---|---|
| Price | $13.74 | $34.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 15 |
| Target Price | ★ $23.67 | $20.25 |
| AVG Volume (30 Days) | 1.3M | ★ 3.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.48 | $7.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $10.56 | $11.17 |
| 52 Week High | $17.88 | $35.65 |
Technical Indicators
Market Signals| Indicator | TAC | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 56.96 | 70.67 |
| Support Level | $13.41 | $16.11 |
| Resistance Level | $14.00 | $35.65 |
| Average True Range (ATR) | 0.51 | 2.41 |
| MACD | 0.02 | 0.23 |
| Stochastic Oscillator | 60.38 | 91.84 |
Price Performance
Historical ComparisonAbout TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse electrical power generation assets in Canada, the United States, and Western Australia. The company has reportable segments namely, Hydro, Wind & Solar, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).